Photocure ASA

Jiangsu Yahong Meditech Co. Ltd. (previously Asieris Pharma), a clinical-stage Chinese biotech focused on small molecules for bladder cancer, has become the first Chinese drug maker to go public in 2

Inovio Pharmaceuticals, Inc. has reported mixed but nonetheless encouraging top-line Phase III data from its leading candidate DNA-based immunotherapy, VGX-3100, in patients with human papillomavirus

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker . Menarini To Pay $11.50 Per Share In

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Altimmune Targets Upstream A